SCHEMBL820750

SCHEMBL820750

CCCCc1cccc([O])c1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ LPL P06858 3/20 0.49
▸ LIPG Q9Y5X9 3/20 0.49
▸ XIAP P98170 1/20 0.45
▸ SKP2 Q13309 1/20 0.44
▸ PPARG P37231 3/20 0.44
▸ PPARA Q07869 3/20 0.44
▸ HPGD P15428 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ PLK1 P53350 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4276383 0.94 LPL (0.56) LPLLIPGPPARGPPARA
SCHEMBL8034266 0.92 LPL (0.57) LPLLIPGPPARGPPARA
SCHEMBL9435711 0.92 LPL (0.57) LPLLIPGPPARGPPARA
SCHEMBL985766 0.92 LPL (0.57) LPLLIPGPPARGPPARA
SCHEMBL6270970 0.92 LPL (0.57) LPLLIPGPPARGPPARA
SCHEMBL28504547 0.92 LPL (0.57) LPLLIPGPPARGPPARA
SCHEMBL10406817 0.92 LPL (0.57) LPLLIPGPPARGPPARA
SCHEMBL1805140 0.87 CNR1 (0.42) LPLLIPGPLK1
SCHEMBL347126 0.84 LPL (0.57) LPLLIPGXIAPSKP2PPARG
SCHEMBL5542870 0.81 HTR2A (0.48) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4365180-A1 RARE EARTH COMPLEX Tosoh Corporation (JP) 2024-05-08 — — EP disclosed
CN-117616032-A Rare earth complex 东曹株式会社 2024-02-27 — — CN disclosed
WO-2023190472-A1 CYCLOHEXYLENEDIAMINIUM SALT, USE THEREOF, AND MSE TYPE ZEOLITE OBTAINED USING SAME 公益財団法人相模中央化学研究所 2023-10-05 — — WO disclosed
CN-111406059-B Europium complexes 东曹株式会社 2023-04-18 — — CN disclosed
CN-113166289-B Composite resin aqueous dispersion and method for producing composite resin aqueous dispersion 三洋化成工业株式会社 2023-04-07 — — CN disclosed
WO-2023282236-A1 RARE EARTH COMPLEX 東ソー株式会社 2023-01-12 — — WO disclosed
US-10988494-B2 Europium complex TOSOH CORPORATION (JP) 2021-04-27 — — US disclosed
US-20200354389-A1 EUROPIUM COMPLEX SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) 2020-11-12 — — US disclosed
CN-111406059-A Europium complexes 东曹株式会社 2020-07-10 — — CN disclosed
US-10451967-B2 Acid- and radical-generating agent and method for generating acid and radical FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-10-22 — — US disclosed
US-5817843-A Quinizarin compound, method for production thereof, and use therefor NIPPON SHOKUBAI CO., LTD. (JP) 1998-10-06 — — US disclosed
EP-0833203-A1 Color filter grade photosensitive resin coloring composition, and color filter using the same NIPPON SHOKUBAI CO., LTD. (JP) 1998-04-01 — — EP disclosed
EP-0552925-B1 Equilibration of cyclic siloxanes with catalysts DOW CORNING (US) 1997-04-09 — — EP disclosed
US-5608091-A SHEETS FOR HEAT EXCHANGING AND OPTICAL RECORDING MATERIAL NIPPON SHOKUBAI CO., LTD. (JP) 1997-03-04 — — US disclosed
EP-0661350-A1 Quinizarin compound, method for production thereof, and use therefor NIPPON SHOKUBAI CO., LTD. (JP) 1995-07-05 — — EP disclosed
EP-0552925-A2 Equilibration of cyclic siloxanes with novel catalysts DOW CORNING CORPORATION (US) 1993-07-28 — — EP disclosed
US-5196559-A Rearrangement to yield higher molecular weight DOW CORNING CORPORATION (US) 1993-03-23 — — US disclosed
EP-0351615-B1 PROCESS FOR THE PREPARATION OF 4-ALKOXY-2-HYDROXYBENZOPHENONE-5-SULFONIC ACIDS BASF Aktiengesellschaft (DE) 1992-10-28 — — EP disclosed
US-5072034-A PREPARATION OF 4-ALKOXY-2-HYDROXYBENZOPHENONE-5-SULFONIC ACIDS BASF AKTIENGESELLSCHAFT (DE) 1991-12-10 — — US disclosed
EP-0351615-A1 Process for the preparation of 4-alkoxy-2-hydroxybenzophenone-5-sulfonic acids BASF Aktiengesellschaft (DE) 1990-01-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10451967-B2 Acid- and radical-generating agent and method for generating acid and radical CBR1, HAO2, CBR3 LPL 2477/4885LIPG 3948/4885XIAP 4469/4885
US-10988494-B2 Europium complex SSB, XPA, UACA LPL 2155/4885LIPG 2237/4885XIAP 1701/4885
US-20200354389-A1 EUROPIUM COMPLEX SSB, XPA, UACA LPL 2155/4885LIPG 2237/4885XIAP 1701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback